Eastgate Biotech Stock Price, News & Analysis
Company Description
Eastgate Biotech (OTC Link: ETBI) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $3.2M.
ETBI stock has declined 75.0% over the past year. Shares last traded at $0.0010.
This page provides a comprehensive overview of ETBI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eastgate Biotech (ETBI) stock last traded at $0.0010. Over the past 12 months, the stock has lost 75.0%. At a market capitalization of $3.2M, ETBI is classified as a micro-cap stock with approximately 717.3M shares outstanding.
Latest News
Eastgate Biotech has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all ETBI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Eastgate Biotech (ETBI) currently stands at 2.5 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Eastgate Biotech (ETBI) currently stands at 1.0 days, down 58.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 86% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ETBI Company Profile & Sector Positioning
Eastgate Biotech (ETBI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ETBI often look at related companies in the same sector, including Nascent Biotech (NBIO), Aptose Bioscienc (APTOF), Zelira Therapeutics Limited (ZLDAF), Mosaic Immunoengineering Inc (CPMV), and Avenue Therapeutics Inc (ATXI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ETBI's relative position within its industry.